Recombinant multi-species PDE4B protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PDE4B protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene is a member of the type IV, cyclic AMP (cAMP)-specific, cyclic nucleotide phosphodiesterase (PDE) family. The encoded protein regulates the cellular concentrations of cyclic nucleotides and thereby play a role in signal transduction. Altered activity of this protein has been associated with schizophrenia and bipolar affective disorder. Alternative splicing and the use of alternative promoters results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2014]
The Alternative Names of target: 3',5'-cyclic-AMP phosphodiesterase 4B,DPDE4,Dpde4,PDE32,PDE4/IVb,PDE4B,PDEIVB,Pde4B1,Pde4B2,Pde4B3,Pde4B4,Pde4b,Pde4b5,Pde4b_v1,Pde4b_v2,Pde4b_v3,Pde4b_v4,cAMP-specific phosphodiesterase 4B,dunce
Go
to PDE4B products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP0041-Ag-1/ GM-Tg-hg-IP0041-Ag-2 | Human PDE4B protein | Human |
| GM-Tg-rg-IP0041-Ag-1/ GM-Tg-rg-IP0041-Ag-2 | Rat PDE4B protein | Rat |
| GM-Tg-mg-IP0041-Ag-1/ GM-Tg-mg-IP0041-Ag-2 | Mouse PDE4B protein | Mouse |
| GM-Tg-cynog-IP0041-Ag-1/ GM-Tg-cynog-IP0041-Ag-2 | Cynomolgus/Rhesus macaque PDE4B protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP0041-Ag-1/ GM-Tg-felg-IP0041-Ag-2 | Feline PDE4B protein | Feline |
| GM-Tg-cang-IP0041-Ag-1/ GM-Tg-cang-IP0041-Ag-2 | Canine PDE4B protein | Canine |
| GM-Tg-bovg-IP0041-Ag-1/ GM-Tg-bovg-IP0041-Ag-2 | Bovine PDE4B protein | Bovine |
| GM-Tg-equg-IP0041-Ag-1/ GM-Tg-equg-IP0041-Ag-2 | Equine PDE4B protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP0041-Ag-1/ GM-Tg-hg-IP0041-Ag-2;
GM-Tg-rg-IP0041-Ag-1/ GM-Tg-rg-IP0041-Ag-2;
GM-Tg-mg-IP0041-Ag-1/ GM-Tg-mg-IP0041-Ag-2; GM-Tg-cynog-IP0041-Ag-1/ GM-Tg-cynog-IP0041-Ag-2; GM-Tg-felg-IP0041-Ag-1/ GM-Tg-felg-IP0041-Ag-2; GM-Tg-cang-IP0041-Ag-1/ GM-Tg-cang-IP0041-Ag-2; GM-Tg-bovg-IP0041-Ag-1/ GM-Tg-bovg-IP0041-Ag-2; GM-Tg-equg-IP0041-Ag-1/ GM-Tg-equg-IP0041-Ag-2 |
| Products Name | PDE4B protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | PDE4B |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PDE4B protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.